The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.

 
Web www.patentalert.com

< Specific mechanism for inhibiting platelet adhesion to collagen

> Aryl sulfonic pyridoxines as antiplatelet agents

~ 00481